Metabolic dysfunction-associated steatotic liver disease and risk of cardiovascular disease
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Metabolic dysfunction-associated steatotic liver disease and risk of cardiovascular disease
Authors
Keywords
-
Journal
GUT
Volume -, Issue -, Pages gutjnl-2023-331003
Publisher
BMJ
Online
2023-11-01
DOI
10.1136/gutjnl-2023-331003
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- AASLD practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease
- (2023) Mary E. Rinella et al. HEPATOLOGY
- The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review
- (2023) Zobair M. Younossi et al. HEPATOLOGY
- Hepatic steatosis and metabolic risk factors among patients with chronic hepatitis B: The multicentre, prospective CAP‐Asia study
- (2023) Yong‐Wen Leow et al. JOURNAL OF VIRAL HEPATITIS
- A multi-society Delphi consensus statement on new fatty liver disease nomenclature
- (2023) Mary E. Rinella et al. HEPATOLOGY
- What is in a name? Toward culturally sensitive nomenclature for liver disease in the east and west
- (2023) W. Ray Kim 金雄來 et al. HEPATOLOGY
- An international multidisciplinary consensus statement on MAFLD and the risk of CVD
- (2023) Xiao-Dong Zhou et al. Hepatology International
- National General Health Screening Program in Korea: history, current status, and future direction: A scoping review
- (2022) Dong Wook Shin et al. Precision and Future Medicine
- Are there outcome differences between NAFLD and metabolic‐associated fatty liver disease?
- (2022) Zobair M. Younossi et al. HEPATOLOGY
- Long-term cardiovascular outcomes differ across metabolic dysfunction-associated fatty liver disease subtypes among middle-aged population
- (2022) Hokyou Lee et al. Hepatology International
- Metabolic dysfunction-associated fatty liver disease and implications for cardiovascular risk and disease prevention
- (2022) Xiao-Dong Zhou et al. Cardiovascular Diabetology
- Liver-related Mortality is Increased in Lean Subjects with Non- alcoholic Fatty Liver Disease Compared to Overweight and Obese Subjects
- (2021) Alexandra Feldman et al. Journal of Gastrointestinal and Liver Diseases
- Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis
- (2021) Alessandro Mantovani et al. Lancet Gastroenterology & Hepatology
- Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease
- (2021) Arun J. Sanyal et al. NEW ENGLAND JOURNAL OF MEDICINE
- MAFLD Enhances Clinical Practice for Liver Disease in the Asia-Pacific region
- (2021) Takumi Kawaguchi et al. Clinical and Molecular Hepatology
- MAFLD: A consensus-driven proposed nomenclature for metabolic associated fatty liver disease
- (2020) Mohammed Eslam et al. GASTROENTEROLOGY
- Nonalcoholic Fatty Liver Disease and Sarcopenia Are Independently Associated With Cardiovascular Risk
- (2020) Eugene Han et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
- (2020) Mohammed Eslam et al. JOURNAL OF HEPATOLOGY
- Comparison of MAFLD and NAFLD diagnostic criteria in real world
- (2020) Su Lin et al. LIVER INTERNATIONAL
- MAFLD identifies patients with significant hepatic fibrosis better than NAFLD
- (2020) Sakura Yamamura et al. LIVER INTERNATIONAL
- Metabolic Dysfunction-Associated Fatty Liver Disease and Incident Cardiovascular Disease Risk: A Nationwide Cohort Study
- (2020) Hokyou Lee et al. Clinical Gastroenterology and Hepatology
- Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease
- (2018) Eduardo Vilar-Gomez et al. GASTROENTEROLOGY
- Metabolic syndrome epidemic among Korean adults: Korean survey of Cardiometabolic Syndrome (2018)
- (2018) Ji Hye Huh et al. ATHEROSCLEROSIS
- Data Resource Profile: The National Health Information Database of the National Health Insurance Service in South Korea
- (2016) Sang Cheol Seong et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
- (2016) JOURNAL OF HEPATOLOGY
- Non–Laboratory-Based Self-Assessment Screening Score for Non-Alcoholic Fatty Liver Disease: Development, Validation and Comparison with Other Scores
- (2014) Yong-ho Lee et al. PLoS One
- The Impact of Obesity and Metabolic Syndrome on Alcoholic Liver Disease
- (2013) Dian J. Chiang et al. Clinics in Liver Disease
- Chronic HCV infection is a risk of atherosclerosis. Role of HCV and HCV-related steatosis
- (2012) Luigi E. Adinolfi et al. ATHEROSCLEROSIS
- Updating and Validating the Charlson Comorbidity Index and Score for Risk Adjustment in Hospital Discharge Abstracts Using Data From 6 Countries
- (2011) H. Quan et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Hepatic steatosis index: A simple screening tool reflecting nonalcoholic fatty liver disease
- (2009) Jeong-Hoon Lee et al. DIGESTIVE AND LIVER DISEASE
- Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease
- (2008) S A Harrison et al. GUT
- Alcohol Consumption and the CAGE Questionnaire in Korean Adults: Results from the Second Korea National Health and Nutrition Examination Survey
- (2008) Jong-Tae Park et al. JOURNAL OF KOREAN MEDICAL SCIENCE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started